AI Article Synopsis

  • Hepatic artery pseudoaneurysm is a serious complication after liver transplants, and treatment options include ligation or endovascular techniques.
  • A 62-year-old male with a second liver transplant developed a pseudoaneurysm due to infection and underwent an endovascular approach using covered stent grafts to isolate the aneurysm.
  • The patient's condition improved, with stable hepatic function and a patent stent after 6 months, suggesting that endovascular stent-graft placement may be a preferable option to traditional surgery in such cases.

Article Abstract

Background: Hepatic artery pseudoaneurysm is a rare but very morbid complication after liver transplant. Treatment options include ligation or endovascular embolization, followed by revascularization. We describe a new endovascular approach by stent exclusion in a high-risk patient.

Results: A 62-year-old male who received a second liver transplant after failed allograft presented with hemobilia and was diagnosed with a hepatic artery pseudoaneurysm in the setting of infection. Given his hostile abdomen, an endovascular approach was sought. We excluded the mycotic pseudoaneurysm with multiple covered stent grafts extending from the common hepatic artery to the right and left hepatic arteries. He was discharged with long-term antibiotics. On his 6-month follow-up visit, his stent was patent and hepatic function was stable.

Conclusions: Endovascular stent-graft placement for management of hepatic artery pseudoaneurysm after liver transplant should be considered as a lower morbidity alternative to surgical repair, even in the setting of infection.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.avsg.2019.05.060DOI Listing

Publication Analysis

Top Keywords

liver transplant
16
hepatic artery
16
artery pseudoaneurysm
12
mycotic pseudoaneurysm
8
pseudoaneurysm liver
8
endovascular approach
8
setting infection
8
hepatic
7
endovascular
5
pseudoaneurysm
5

Similar Publications

Hypothermic oxygenated machine perfusion (HOPE) preconditions liver grafts before transplantation. While beneficial effects on patient outcomes were demonstrated, biomarkers for viability assessment during HOPE are scarce and lack validation. This study aims to validate the predictive potential of perfusate flavin mononucleotide (FMN) during HOPE to enable the implementation of FMN-based assessment into clinical routine and to identify safe organ acceptance thresholds.

View Article and Find Full Text PDF

In vivo selection of hepatocytes.

Hepatology

October 2024

Department of Pediatrics, Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, Oregon, USA.

The liver is a highly regenerative organ capable of significant proliferation and remodeling during homeostasis and injury responses. Experiments of nature in rare genetic diseases have illustrated that healthy hepatocytes may have a selective advantage, outcompete diseased cells, and result in extensive liver replacement. This observation has given rise to the concept of therapeutic liver repopulation by providing an engineered selective advantage to a subpopulation of beneficial hepatocytes.

View Article and Find Full Text PDF

A family with gallstone disease: defining inherited risk in the era of clinical genetic testing.

Intern Emerg Med

January 2025

Department of Gastroenterology, Hepatology and Transplant Medicine, Medical Faculty, University of Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany.

Gallstones are among the most frequent hepatobiliary conditions. Although in most cases, they remain asymptomatic, they can cause complications and, in such cases, invasive treatments like endoscopic retrograde cholangiography (ERC) or cholecystectomy are required. Here, we present the results of genetic testing of a single family with a high incidence of symptomatic gallstones and cholestatic liver phenotypes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!